Ceapro Inc. (CVE:CZO – Get Free Report) shares traded up 8.7% during mid-day trading on Friday . The company traded as high as C$0.25 and last traded at C$0.25. 1,000 shares were traded during trading, a decline of 97% from the average session volume of 32,081 shares. The stock had previously closed at C$0.23.
Ceapro Price Performance
The business has a fifty day moving average of C$0.19 and a 200-day moving average of C$0.27. The firm has a market cap of C$19.57 million, a PE ratio of -8.33 and a beta of 1.39. The company has a current ratio of 11.00, a quick ratio of 18.88 and a debt-to-equity ratio of 7.82.
Ceapro Company Profile
Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Read More
- Five stocks we like better than Ceapro
- How Technical Indicators Can Help You Find Oversold Stocks
- MarketBeat Week in Review – 3/11 – 3/15
- Want to Profit on the Downtrend? Downtrends, Explained.
- Why Dollar General and Dollar Tree Are Similar Yet Different
- Insider Buying Explained: What Investors Need to Know
- Jabil Stock Implodes: Market Manufactures Entry for New Money
Receive News & Ratings for Ceapro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceapro and related companies with MarketBeat.com's FREE daily email newsletter.